LOVENOX FINESSE
Aventis Pharma S.A.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86767218 |
| Registration Number | 4976938 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Karen Lim |
| Attorney Name | Karen Lim |
| Attorney Docket Number | AVPS 1506784 |
| Law Office Assigned | N20 |
| Employee Name | YOO, JEANE |
Timeline
| 2015-09-24 | Application Filed |
| 2016-03-29 | Published for Opposition |
| 2016-06-14 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-06-14 | Status: Live/Registered |
| 2016-06-14 | Trademark Registered |
| 2020-01-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Aventis Pharma S.A. |
| Address | 20, avenue Raymond Aron Antony FR 92160 |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical product, namely, an antithrombotic drug |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-09-28 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-09-30 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2016-01-13 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2016-01-13 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2016-01-13 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-01-13 | 6 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2016-01-19 | 7 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2016-01-28 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-01-29 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-01-29 | 10 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-02-18 | 11 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-02-23 | 12 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-03-09 | 13 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-03-29 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-03-29 | 15 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-06-14 | 16 R.PR A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-31 | 17 CRFA I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2017-04-05 | 18 CORV 1: |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-10 | 19 CRFA I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2020-01-08 | 20 CORV 1: |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-02-26 | 21 ASGN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-06-14 | 22 REM1 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-11-04 | 23 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-04 | 24 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-04 | 25 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-04 | 26 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-11-04 | 27 CHAN I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2022-12-30 | 28 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LOVENOX FINESSE 86772048 5001899 Live/Registered |
Aventis Pharma S.A. 2015-09-29 |
 LOVENOX FINESSE 86767218 4976938 Live/Registered |
Aventis Pharma S.A. 2015-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 